Publication | Open Access

Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 study

Hematological MalignancyDose-escalation Phase 1OncologyMyelodysplastic SyndromeMixed-phenotype Acute LeukemiaHematologyMyeloid NeoplasiaAcute Myeloid LeukaemiaPharmacotherapyMedicineRadiation OncologyHealth Sciences